215543-92-3Cc1c[nH]c(C=C2C(=O)Nc3ccccc32)c1CCC(=O)OJNDVEAXZWJIOKB-UHFFFAOYSA-N215543-92-3CHEMBL3188898Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
DescriptionSU-5402 (215543-92-3) inhibits FGFR phosphorylation in vitro, in cell culture1, and in mouse tumor cell models2. SU-5402 can suppress ECP induced cardiomyocyte differentiation of P19CL6 embryonic carcinoma cells via an FGFR3 dependent pathway.3
UsesSU 5402 is a specific FGFR (fibroblast growth factor receptor) inhibitor (1,2,3,4). It is also an intermediate for 3-(hetero)arylmethylidene-2-indolinone derivatives as modulators of protein kinase activity for use in treating cancer.
UsesSU5402 has been used as a fibroblast growth factor receptor inhibitor:in cell signalling experiments to stimulate cells for MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assayto study its effect on the expression of osteogenic markers and expression of osteoprotegerin and RANKL (runt-related transcription factor(RUNX)-2to prepare a stock solution with DMSO (Dimethyl superoxide) for cell culture medium and also to co-treat embryosto study its effect on osteogenic markers.
UsesA specific FGFR (fibroblast growth factor receptor er.
DefinitionChEBI: An oxindole that is 3-methyleneoxindole in which one of the hydrogens of the methylene group is substituted by a 3-(2-carboxyethyl)-4-methyl-1H-pyrrol-2-yl group. It is an ATP-competitive inhibitor of the tyrosine kinase activity of fibr blast growth factor receptor 1.
No reaction records under the current filter.
Loading…